Lifeline Business Profile
Stem cells from cord blood used to treat infant cerebral palsy.
LFLN REF 25/09/12 p.70
Stem cells from cord blood used to treat infant cerebral palsy.
LFLN REF 25/09/12 p.70
The facility of CBB Lifeline Biotech is Accredited by AABB International Standards for Cellular Therapy Products for Cord Blood Banking Services
Since October 2020 the clinical testing is performed by a third party accredited collaborator
LifeCord Patented Methodology
US Patent Office
